Vivek Y Reddy
Overview
Explore the profile of Vivek Y Reddy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
428
Citations
11530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doshi R, Ip J, Defaye P, Reddy V, Exner D, Canby R, et al.
Heart Rhythm
. 2025 Mar;
PMID: 40089049
Background: Initial results were recently reported for the AVEIR DR i2i study which involved the percutaneous implantation of a novel dual-chamber leadless pacemaker (LP) system, with right atrial (RA) and...
2.
Mountantonakis S, Gerstenfeld E, Mansour M, Cuoco F, Natale A, Patel C, et al.
Heart Rhythm
. 2025 Mar;
PMID: 40057295
Background: Pulsed field ablation (PFA) has proven to be at least non-inferior to thermal ablation for paroxysmal atrial fibrillation (PAF). Predictors of AF freedom for PFA have not yet been...
3.
Aldaas O, Reddy V, Verma A, Natale A, Peichl P, Schmidt B, et al.
Circ Arrhythm Electrophysiol
. 2025 Feb;
:e013294.
PMID: 39989360
No abstract available.
4.
Kiehl E, Mountantonakis S, Mansour M, Nair D, Sharma D, Taigen T, et al.
Heart Rhythm
. 2025 Feb;
PMID: 39922404
Background: The SPHERE Per-AF trial demonstrated noninferiority for a primary composite effectiveness endpoint in patients with persistent atrial fibrillation (AF) treated with a 9-mm, lattice-tip, pulsed field (PF)/radiofrequency (RF) system...
5.
Urbanek L, Heine G, Reddavid C, Saw J, Kawamura I, Reddy V, et al.
JACC Clin Electrophysiol
. 2025 Jan;
11(1):71-82.
PMID: 39880544
Background: The net benefit of oral anticoagulation in patients with end-stage renal disease on hemodialysis (HD) is uncertain. In recent years, left atrial appendage closure (LAAC) has emerged as an...
6.
Scherr D, Turagam M, Maury P, Blaauw Y, van der Voort P, Neuzil P, et al.
Europace
. 2025 Jan;
PMID: 39824172
Background: Initial clinical studies of pulsed field ablation (PFA) to treat atrial fibrillation (AF) indicated a >90% durability rate of pulmonary vein isolation (PVI). However, these studies were largely conducted...
7.
Di Biase L, Reddy V, Bahu M, Newton D, Liu C, Sauer W, et al.
Europace
. 2025 Jan;
27(2).
PMID: 39820338
Aims: Studies have shown correlations between early recurrence (ER) and late recurrence (LR) of atrial arrhythmia after ablation with thermal technologies. This admIRE trial (NCT05293639) subanalysis aims to analyse ER...
8.
Nilsson K, Castellano S, Kong M, Derejko P, Szili-Torok T, Goyal S, et al.
J Cardiovasc Electrophysiol
. 2025 Jan;
36(3):589-599.
PMID: 39817626
Background: Electrographic flow (EGF) mapping allows for the visualization of global atrial wavefront propagations. One mechanism of initiation and maintenance of atrial fibrillation (AF) is stimulation from EGF-identified focal sources...
9.
Neuzil P, Exner D, Knops R, Cantillon D, Defaye P, Banker R, et al.
J Am Coll Cardiol
. 2025 Jan;
PMID: 39772361
Background: The growing use of leadless pacemaker (LP) technology requires safe and effective solutions for retrieving and removing these devices over the long term. Objectives: This study sought to evaluate...
10.
Padula W, Paffrath A, Jacobsen C, Cohen B, Nadboy R, Sutton B, et al.
J Med Econ
. 2024 Dec;
28(1):127-135.
PMID: 39694707
Background: Pulsed field ablation (PFA) has emerged as an effective technology in the treatment of paroxysmal atrial fibrillation (AF). Objective: To evaluate the cost-effectiveness of PFA vs. thermal ablation from...